InviMed

What InviMed does

InviMed is a Polish fertility clinic network founded in 2001 and operated by the legal entity Medi Partner Sp. z o.o. as part of the broader Medicover Group. The company runs six clinics across major Polish cities — Warsaw (Mokotów and Praga districts), Wrocław, Poznań, Gdynia, and Katowice — providing infertility diagnostics, in vitro fertilization (IVF), intrauterine insemination, oocyte and sperm donation programs, fertility preservation including oncofertility, and gynecological and urogynecological physiotherapy. It claims over 13,000 children born through its treatments and a 65% pregnancy success rate, positioning itself as the first IVF clinic established in Poland.

The core technology stack is the embryology laboratory, where InviMed deploys advanced sperm-selection and embryo-handling techniques: ICSI, IMSI at 6,000x magnification, PICSI® hyaluronan-binding selection, two-stage hbIMSI, Oosight™ polarized-light oocyte evaluation, ZyMōt microfluidic chips, EmbryoGlue® transfer medium, vitrification, and preimplantation genetic testing (PGT-A and PGT-M). The diagnostic menu extends to semen analysis, AMH ovarian reserve testing, the eBIOM endometrial microbiome test, Test Adventia, Test Rodinia, NutriGen nutrigenetic testing, and VERACITY non-invasive prenatal testing. Adjacent services include psychological support, acupuncture, urogynecological physiotherapy, and aesthetic gynecology (MonaLisa Touch laser) at the Gdynia clinic. Patient acquisition runs through a 500 900 888 hotline, online booking forms, walk-in registration, organic search, a multilingual blog, social media, the MediClub loyalty program, the Medicover insurance network, and Poland's National Health Fund (NFZ) IVF reimbursement program (up to three subsidized cycles for eligible patients). Private IVF cycles are priced at 8,000–15,000 PLN (~$2,000–$3,800), and revenue is generated on a fee-for-service basis across both private and publicly funded channels.

Name

InviMed

Legal name

Medi Partner Sp. z o.o.

Website

https://invimed.pl

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

101–250 employees

Short description

InviMed is a Polish fertility clinic network founded in 2001, operating six locations and providing IVF, insemination, fertility preservation, genetic testing, and gynecological care to individuals and couples experiencing infertility.

Ownership category

akta.pro rank

Product category

Fertility Clinics and Reproductive Medicine

NAICS

Offices of Physicians (6211), Other Ambulatory Health Care Services (6219)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro industry

PRIMARYHLAFAJAD

Fertility, Reproductive Endocrinology & IVF Centers

Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers

SECONDARYHLAKAJAC

Reproductive Endocrinology & Infertility (IVF/Fertility)

Healthcare & Life Sciences/Specialist Medical Practice/Obstetrics & Gynecology (OB/GYN)

SECONDARYHLALAHAK

Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling)

Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)

Keywords

• Fertility treatment
• In vitro fertilization
• Reproductive medicine
• Fertility diagnostics
• Assisted reproduction

Headquarters

HQ city

Warszawa

HQ country

Poland

HQ region

Europe

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Private Medical Services: Direct patient payments for fertility treatments including IVF, insemination, diagnostics, genetic testing, and consultations. Services available at all 6 clinic locations on a fee-for-service basis.
2. Government IVF Reimbursement (NFZ): Participation in the national public IVF subsidy program. Patients meeting eligibility criteria can receive reimbursement for up to 3 IVF attempts. Also includes regional subsidies such as for residents of Mazovia voivodeship.
3. MediClub Loyalty Program: Free discount program offering reduced prices on consultations and treatments for enrolled members.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

InviMed operates a network of fertility clinics in Poland delivering assisted reproduction services, including in vitro fertilization (IVF), intrauterine insemination (IUI), fertility diagnostics, embryology and andrology laboratory work, preimplantation and prenatal genetic testing, and gamete/embryo cryopreservation. The clinics serve individuals and couples seeking to conceive, including patients enrolled through the state-funded NFZ program and self-paying private patients.

Product overview

Invimed is a network of infertility treatment clinics offering a comprehensive portfolio of assisted reproduction services. The core offering centers on In vitro (IVF) fertilization, supplemented by intrauterine insemination and oocyte adoption programs. The company provides extensive diagnostic services including genetic testing (Test Adventia, eBIOM, Test Rodinia, NutriGen), prenatal testing (VERACITY), AMH testing, semen analysis, and endometriosis diagnostics. Advanced laboratory techniques include ICSI, IMSI, PICSI®, hbIMSI, the Oosight™ oocyte evaluation system, EmbryoGlue®, vitrification, and embryo adoption with a guarantee of three high-quality embryos. Supporting services include fertility preservation (egg freezing, oncofertility), urogynecological physiotherapy, psychological support, and acupuncture. The company operates six clinics across Poland (Warsaw Mokotów, Warsaw Praga, Wrocław, Poznań, Gdynia, Katowice) and offers both private services and government-funded IVF reimbursement programs.

Differentiator

Problem solved

Functional benefit

Brands

• MediClub: Free discount program for Invimed patients offering various benefits and savings on services.
• Oocyte Adoption Programme with Guarantee

Products and services

• In Vitro Fertilization (IVF / ICSI)

Quantifiable outcome

• 65% pregnancy rate
• +2 more outcomes

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Medi Partner Sp. z o.o.coreOthersMedi Partner Sp. z o.o. is the parent company operating the InviMed clinics. The company is part of the Medicover Group (Grupa Medicover), a larger healthcare services organization. Medi Partner handles data processing, operations, and administration for InviMed fertility clinics.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Gyncentrum: Polish fertility and reproductive medicine clinic based in Katowice and other cities, offering IVF, ICSI, egg donation, and genetic diagnostics — a direct competitor in the same Polish patient market with similar service breadth.
• Vitrolive: Polish IVF clinic chain with multiple locations, competing head-to-head with InviMed on IVF/ICSI, egg donation programs, and PGT, often referenced in the same competitive set by Polish patients.
• Klinika Bocian: Polish fertility clinic chain operating multiple sites across major Polish cities, directly competing with InviMed on IVF, IUI, and genetic testing with overlapping payor mix including private and NFZ-funded cycles.
• Centrum Medyczne Macierzyństwo: Established Polish fertility clinic offering IVF, IUI, and reproductive diagnostics across several cities, competing for the same NFZ-subsidized and private-pay patients as InviMed.

Broad incumbents

• IVI-RMA Global: One of the world's largest assisted reproduction groups (IVI + RMA), operating across Europe, the Americas, and the Middle East. Comparable as a premium global fertility brand investing in advanced ART lab technology similar to InviMed's IMSI/PICSI stack.
• TFP Fertility: Large European fertility clinic network (UK, Poland, Germany, Netherlands, Austria, Denmark). Comparable as a multi-country IVF operator with overlapping technologies (ICSI, PGT) and similar mix of private and public payors.
• Medicover: Parent healthcare group operating InviMed, Medicover hospitals, and primary care across Poland and CEE. Comparable as the broader healthcare ecosystem InviMed sits within and as a benchmark for clinic-level economics and corporate strategy.
• Virtus Health: Australian-listed global fertility provider with operations in Australia, Ireland, the UK, and Denmark. Comparable as a multi-clinic fertility network with similar service portfolio (IVF, ICSI, PGT, donor programs) at scale.

Regional players

• Genea Biomedx: Australian-headquartered global fertility group (clinics plus medical devices like Gavi, Geri). Comparable as an integrated ART lab technology and clinic operator and as a benchmark for advanced embryo culture and vitrification capabilities used by InviMed.

Others

• Progyny: US fertility benefits and care management company partnering with employer-sponsored plans. Comparable as a model for how employer/insurance-funded fertility care (similar to Medicover's role for InviMed) can be packaged and scaled commercially.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeinvimed.pl/youtube-klauzula-informacyjna
• Facebookfacebook.com/invimed
• Instagraminvimed.pl/instagram-klauzula-informacyjna
• LinkedInlinkedin.com/company/invimed

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InviMed